VIGADRONE® (vigabatrin) is ...

… a prescription medication used to treat:

  • Infantile Spasms (IS) in patients 1 month to 2 years of age, if you and your healthcare provider decide the possible benefits of taking VIGADRONE are more important than the possible risk of vision loss.
  • Refractory Complex Partial Seizures (CPS) in adults and children 2 years and older with refractory complex partial seizures (CPS) along with other treatments if:
    • The CPS do not respond well enough to several other treatments, and
    • You and your healthcare provider decide the possible benefit of taking VIGADRONE is more important than the risk of vision loss.

VIGADRONE should not be the first medicine used to treat CPS.

… available as 500 mg powder for oral solution and 500 mg tablets.

… an equal generic substitute from Upsher-Smith Laboratories, LLC and backed by our Promise of Support.1


The U.S. Food and Drug Administration (FDA) has approved a single shared system Risk Evaluation and Mitigation Strategy (REMS) for all vigabatrin products called the Vigabatrin REMS Program. It is required by the FDA to ensure informed risk-benefit decisions before initiating treatment and to ensure appropriate use of vigabatrin while patients are treated.

Visit the Vigabatrin REMS website for instructions and the FDA-mandated REMS forms.